Dr Andrzej Rutkowski
While in academia, Andrzej worked in different scientific fields, from oncofoetal antigens to herpes viruses. His projects revolved around changes in gene expression, which is where he developed an array of skills transferrable to biomarker research. While in AstraZeneca, he developed and multiplexed droplet digital PCR assays and used them to monitor cancer-related mutations in […]
Dr Maike Langini
M.Sc. Maike Langini obtained her Master’s degree in Bio- and Pharmaceutical Analysis at the Fresenius university of applied sciences in Idstein (Germany). She is finishing her PhD in chemistry at the Heinrich Heine University Düsseldorf (Germany) with Prof Kai Stühler in the Molecular Proteomics Laboratory. Previous research focused on lncRNA based perturbations of protein signatures […]
Dr Philippa Hart
Philippa’s interest in MS imaging began during her PhD studies with the application of MALDI in the group of Prof. Malcolm Clench. Philippa has over 13 years of experience in the field gained in both academia and industry, including roles at both Shimadzu and Waters. During this time she gained experience in clinical applications of […]
Dr Michael Eyres
Michael joined Medicines Discovery Catapult as an intern at the start of 2019 at the end of his PhD in Oncology at Oxford University. Michael stayed at MDC to volunteer at the Lighthouse COVID test labs at the start of the pandemic and then joined MDC as a senior scientist in spatial biomarkers. Now he […]
Dr Lucy Frost
Following a PhD in Molecular Biology from the University of Warwick, Lucy joined Medicines Discovery Catapult in April 2021 as a Postdoctoral Scientist. Lucy has a key role in the biomarkers team to develop bioinformatic tools and pipelines for the visualisation and interpretation of transcriptomic data. Lucy combines knowledge in molecular biology with bioinformatic techniques […]
Dr Kevin Randall
After graduating from Manchester University with a degree in Biochemistry Kevin spent 6 years working in a clinical histopathology laboratory at the Queen’s Medical Centre, Nottingham, where he achieved State Registration as a Biomedical Scientist. In 1997, shortly after gaining a Masters degree in Biomedical Sciences from Nottingham Trent University, he moved to AstraZeneca at […]
Eleanor Platt
Eleanor Platt is a Molecular Scientist within the Biomarkers team at Medicines Discovery Catapult. Eleanor undertook a degree in Molecular and Cellular Biology at the University of Bath and completed her M.Phil. in Molecular Cancer Studies at the University of Manchester, with a focus on the role of glucocorticoid receptor in small cell lung cancer […]
Gayle Marshall
Gayle has more than 20 years of experience, in biomarker and omics research. Leading a large, multi-skilled translational science laboratory team, within a global Pharma department supporting biomarker strategies across 14 drug discovery programs covering more than 20 clinical studies, through to leading a large multi-disciplinary team within MDC. Gayle directs multi-biomarker analysis and assay […]